Category: Wall Street BeatSyndicate content

Hologic swings to Q1 black, raises outlook

January 30, 2015 by Mark Hollmer

Hologic puts black ink back in its fiscal Q1 ledger, meeting The Street with its fiscal 1st-quarter earnings and boosting its sales outlook for the rest of the year.

Hologic swings to Q1 black, raises outlook

Hologic (NSDQ:HOLX) raised its sales guidance for fiscal 2015 after reporting robust fiscal 1st-quarter results.

IPO Thursday: Avinger, Entellus upsize, Presbia prices under range

January 30, 2015 by Brad Perriello

A trio of medical device companies priced their IPOs yesterday, with Avinger and Entellus upsizing their offerings and Presbia pricing under range.

IPO Thursday: Avinger, Entellus upsize, Presbia prices under range

It was medtech IPO day on Wall Street yesterday as a trio of medical device companies priced their initial public offerings.

Asante Solutions sets terms for pending IPO | Medtech Wall Street news for the week of January 26, 2015

January 29, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Asante Solutions sets IPO terms; Stryker CEO Lobo: M&A is our top priority for cash; Abiomed surges on Q3 numbers, FDA nod; Credit agencies lower Medtronic's rating post-Covidien merger

Diabetes: Asante Solutions sets IPO terms

January 23, 2015 by Brad Perriello

Credit agencies lower Medtronic's rating post-Covidien merger

January 28, 2015 by Brad Perriello

Credit agencies Standard & Poor's and Moody's lowered their ratings as promised on Medtronic after it took out a massive debt package to finance its $50 billion acquisition of Covidien.

Credit agencies lower Medtronic's rating post-Covidien merger

Abiomed surges on Q3 numbers, FDA nod

January 28, 2015 by Brad Perriello

Abiomed shares surge to an all-time high after the heart pump maker crushes expectations with its fiscal 3rd-quarter results and raises its outlook for the rest of fiscal 2015.

Abiomed surges on Q3 numbers, FDA nod

Abiomed (NSDQ:ABMD) shares surged to an all-time high today after the heart pump maker crushed expectations for its fiscal 3rd quarter and raised its outlook on the rest of the year.

Stryker CEO Lobo: M&A is our top priority for cash

January 28, 2015 by MassDevice

Stryker CEO Kevin Lobo says acquisitions are the top priority for the $1.8 billion in ready cash the orthopedics giant is carrying on its balance sheet.

Stryker CEO Lobo: M&A is our top priority for cash